Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in house dust mite allergic rhinitis patients

被引：0
|
作者：
Demoly, P. [1 ,2 ]
Pfaar, O. [3 ]
Gevaert, P. [4 ]
Canonica, G. W. [5 ]
Casale, T. [6 ]
Scurati, S. [7 ]
Dolimier, E. [7 ]
机构：
[1] Univ Hosp Montpellier, Montpellier, France
[2] IDESP, Montpellier, France
[3] Philipps Univ Marburg, Univ Hosp Marburg, Marburg, Germany
[4] Univ Ghent, Ghent, Belgium
[5] Humanitas Univ, Milan, Italy
[6] Univ S Florida, Tampa, FL USA
[7] Stallergenes Greer, Antony, France
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000267
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [21] Improvements with sublingual house dust mite immunotherapy in allergic rhinitis Reply
    Demoly, Pascal
    Kleine-Tebbe, Joerg
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (02) : 635 - 635
  • [22] The effects of house dust mite sublingual immunotherapy in allergic rhinitis children
    Park, Y.
    ALLERGY, 2018, 73 : 622 - 622
  • [23] HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET FOR ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS IN MONOSENSITIZED AND POLYSENSITIZED CHILDREN
    Nolte, H.
    Caimmi, D.
    Pfaar, O.
    Bennett, J. Kress
    Foss-Skiftesvik, M.
    Schuster, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S18 - S18
  • [24] SAFETY OF THE HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IN A PEDIATRIC ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS TRIAL
    Caimmi, D.
    Nolte, H.
    Pfaar, O.
    Foss-Skiftesvik, M.
    Osterdal, A.
    Schuster, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S18 - S18
  • [25] Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis
    Okubo, Kimihiro
    Masuyama, Keisuke
    Imai, Toru
    Okamiya, Kazuhiro
    Stage, Brian Sonne
    Seitzberg, Dorthe
    Konno, Akiyoshi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (06) : 1840 - +
  • [26] SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms
    Mosbech, Holger
    Canonica, G. Walter
    Backer, Vibeke
    de Blay, Frederic
    Klimek, Ludger
    Broge, Louise
    Ljorring, Christian
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (02) : 134 - U183
  • [27] Safety of the 300 IR and 500 IR Doses of a House Dust Mite Allergen Extracts Sublingual Tablet in Adults with Allergic Rhinitis
    Nguyen, Helene
    Roux, Michel
    Cognet-Sice, Josiane
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB267 - AB267
  • [28] The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration
    Lin, Zhibin
    Liu, Qihong
    Li, Tianying
    Chen, Dong
    Chen, Dehua
    Xu, Rui
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2016, 6 (01) : 82 - 87
  • [29] Safety of a 300IR house dust mite sublingual immunotherapy (SLIT) solution in patients with moderate, persistent asthma
    Devillier, P.
    Fadel, R.
    de Beaumont, O.
    ALLERGY, 2015, 70 : 258 - 258
  • [30] Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites
    Maloney, Jennifer
    Prenner, Bruce M.
    Bernstein, David I.
    Lu, Susan
    Gawchik, Sandra
    Berman, Gary
    Kaur, Amarjot
    Li, Ziliang
    Nolte, Hendrik
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 116 (01) : 59 - 65
12345